Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metherb: Polyherbal Formulation Add-on to Metformin in T2D
NCT06846138Enrolling by invitation
- Sponsor
- Pauls Stradins Clinical University Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Pauls Stradins Clinical University Hospital. Primary endpoint: Change in Glycemic Control (HbA1c Levels) at 48 weeks. Started Mar 2025; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT06846138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06846138.